WHITEFISH, Mont., April 11, 2013 /PRNewswire/ -- SECFilings.com, a leading provider of SEC filings news and analysis, has issued a media update on Arrayit Corporation (OTCQB: ARYC), a leading developer of life science tools and systems for the analysis of genetic variation, biological function and diagnostics.
In the update, Ryan Allway discusses the company's platform and the role of diagnostics in healthcare costs:
U.S. healthcare costs are skyrocketing and it's no secret that it could bankrupt the country if left unchecked. Medical Payment Advisor Commission chairman Glenn Hackbarth warned lawmakers in March that "pressure on the federal budget would continue as Social Security, Medicare, Medicaid, other health insurance programs, and net interest are projected to account for more than 16% of GDP in 10 years, whereas total federal revenues have averaged just 18.5% of GDP over the past 40 years" – big problems, indeed.
While President Obama's healthcare reform has been a point of contention, there are fewer disagreements around some other ways to lower healthcare costs. For instance, Mr. Hackbarth insisted that increasing primary care physicians, who tend to be more efficient at providing care than specialized doctors, would undoubtedly lower costs. But perhaps more importantly to investors, there are many public companies focused on developing new technologies designed to lower costs and ultimately resolve these big issues facing the U.S. ...
To view the full update, visit SECFilings.com at:http://secfilings.com/News.aspx?title=stocks_with_technologies_that_address_rising_healthcare_costs&naid=339 About SECFilings.com SECFilings.com is a leading provider of SEC filings news and analysis, with more than 600,000 registered members. By providing real-time SEC filing alerts by e-mail or RSS, as well as access to an extensive database of over 7 million filings dating back to 1994, the financial portal has become a leading destination for sophisticated investors looking to track regulatory filings.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV